Inventor · disambiguated record
Eugene R. Cooper
Also filed as: COOPER EUGENE R · COOPER EUGENE REX
55 granted patents·34 pending applications·3,873 citations·filing 1979–2025
99Inventor score
Files withELAN PHARMA INT LTD19STERLING WINTHROP INC12EYEON PARTICLE SCIENCES LLC8MACUSIGHT INC6BOTANIX PHARMACEUTICALS LTD5
Top patents by PatentIndex Score
89 records- 0199US6908626B2Compositions having a combination of immediate release and controlled release characteristicsELAN PHARMA INT LTD·Filed 2002·Granted Jun 21, 2005·167 cites·34 claims
- 0298US6811767B1Liquid droplet aerosols of nanoparticulate drugsELAN PHARMA INT LTD·Filed 2000·Granted Nov 2, 2004·202 cites·28 claims
- 0398US6428814B1Bioadhesive nanoparticulate compositions having cationic surface stabilizersELAN PHARMA INT LTD·Filed 1999·Granted Aug 6, 2002·294 cites·27 claims
- 0498US4557934APenetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-onePROCTER & GAMBLE·Filed 1983·Granted Dec 10, 1985·299 cites·23 claims
- 0598US4537776APenetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidonePROCTER & GAMBLE·Filed 1983·Granted Aug 27, 1985·276 cites·22 claims
- 0696US9884074B2Bi-functional co-polymer use for ophthalmic and other topical and local applicationsEYEON PARTICLE SCIENCES LLC·Filed 2016·Granted Feb 6, 2018·8 cites·19 claims
- 0796US9283248B2Bi-functional co-polymer use for ophthalmic and other topical and local applicationsEYEON PARTICLE SCIENCES LLC·Filed 2015·Granted Mar 15, 2016·9 cites·9 claims
- 0896US9005596B2Bi-functional co-polymer use for ophthalmic and other topical and local applicationsEYEON PARTICLE SCIENCES LLC·Filed 2014·Granted Apr 14, 2015·13 cites·25 claims
- 0996US8802075B2Bi-functional co-polymer use for opthalmic and other topical and local applicationsCOOPER EUGENE R·Filed 2010·Granted Aug 12, 2014·17 cites·37 claims
- 1096US5585108AFormulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable claysNANOSYSTEMS LLC·Filed 1994·Granted Dec 17, 1996·244 cites·4 claims
- 1196US5318767AX-ray contrast compositions useful in medical imagingSTERLING WINTHROP INC·Filed 1992·Granted Jun 7, 1994·291 cites·28 claims
- 1296US4552872APenetrating topical pharmaceutical compositions containing corticosteroidsPROCTER & GAMBLE·Filed 1984·Granted Nov 12, 1985·185 cites·34 claims
- 1395US9295693B2Bi-functional co-polymer use for ophthalmic and other topical and local applicationsEYEON PARTICLE SCIENCES LLC·Filed 2014·Granted Mar 29, 2016·8 cites·28 claims
- 1495US8512727B2Nanoparticulate meloxicam formulationsCOOPER EUGENE R·Filed 2004·Granted Aug 20, 2013·134 cites·19 claims
- 1595US7585517B2Transscleral deliveryMACUSIGHT INC·Filed 2004·Granted Sep 8, 2009·101 cites·31 claims
- 1695US5451393AX-ray contrast compositions useful in medical imagingEASTMAN KODAK CO·Filed 1994·Granted Sep 19, 1995·171 cites·21 claims
- 1794US11110119B2Bi-functional co-polymer use for ophthalmic and other topical and local applicationsEYEON PARTICLE SCIENCES LLC·Filed 2020·Granted Sep 7, 2021·2 cites·19 claims
- 1894US10729715B2Bi-functional co-polymer use for ophthalmic and other topical and local applicationsEYEON PARTICLE SCIENCES LLC·Filed 2018·Granted Aug 4, 2020·4 cites·20 claims
- 1994US7288267B2Bioadhesive nanoparticulate compositions having cationic surface stabilizersELAN PHARMA INT LTD·Filed 2001·Granted Oct 30, 2007·51 cites·81 claims
- 2094US7198795B2In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositionsELAN PHARMA INT LTD·Filed 2002·Granted Apr 3, 2007·62 cites·19 claims
- 2194US5466440AFormulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable claysEASTMAN KODAK CO·Filed 1994·Granted Nov 14, 1995·155 cites·8 claims
- 2294US4954487APenetrating topical pharmaceutical compositionsPROCTER & GAMBLE·Filed 1989·Granted Sep 4, 1990·231 cites·8 claims
- 2393US5565188APolyalkylene block copolymers as surface modifiers for nanoparticlesNANOSYSTEMS LLC·Filed 1995·Granted Oct 15, 1996·278 cites·6 claims
- 2492US5618528ABiologically compatible linear block copolymers of polyalkylene oxide and peptide unitsSTERLING WINTHROP INC·Filed 1994·Granted Apr 8, 1997·134 cites·17 claims
- 2591US7763278B2Nanoparticulate polycosanol formulations and novel polycosanol combinationsELAN PHARMA INT LTD·Filed 2003·Granted Jul 27, 2010·42 cites·66 claims
- 2691US5221696AUse of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugsALCON LAB INC·Filed 1991·Granted Jun 22, 1993·133 cites·22 claims
- 2788US10463673B2Nanoparticulate meloxicam formulationsRECRO PHARMA INC·Filed 2018·Granted Nov 5, 2019·4 cites·4 claims
- 2888US7850995B2Bioadhesive nanoparticulate compositions having cationic surface stabilizersELAN PHARMA INT LTD·Filed 2007·Granted Dec 14, 2010·4 cites·9 claims
- 2988US7695739B2In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositionsELAN PHARMA INT LTD·Filed 2007·Granted Apr 13, 2010·6 cites·18 claims
- 3086US10709713B2Nanoparticulate meloxicam formulationsBAUDAX BIO INC·Filed 2019·Granted Jul 14, 2020·1 cites·10 claims
- 3185US8623412B2Abuse-resistant pharmaceutical compositionsVAGHEFI FARID·Filed 2003·Granted Jan 7, 2014·25 cites·7 claims
- 3283US12280073B2Bi-functional co-polymer use for ophthalmic and other topical and local applicationsCALM WATER THERAPEUTICS LLC·Filed 2023·Granted Apr 22, 2025·0 cites·4 claims
- 3382US8309136B2In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositionsCOOPER EUGENE R·Filed 2010·Granted Nov 13, 2012·3 cites·14 claims
- 3482US8124057B2Propellant-based nanoparticulate dry powder aerosols and method of makingBOSCH H WILLIAM·Filed 2009·Granted Feb 28, 2012·4 cites·9 claims
- 3580US7521068B2Dry powder aerosols of nanoparticulate drugsELAN PHARMA INT LTD·Filed 1998·Granted Apr 21, 2009·34 cites·106 claims
- 3680US7390505B2Nanoparticulate topiramate formulationsELAN PHARMA INT LTD·Filed 2004·Granted Jun 24, 2008·16 cites·107 claims
- 3780US5705194APharmaceutical compositions containing polyalkylene block copolymers which gel at physiological temperatureNANOSYSTEMS LLC·Filed 1996·Granted Jan 6, 1998·52 cites·7 claims
- 3879US9283177B2Topical anesthetic for rapid local anesthesia and method of applying a topical anestheticCOHEN DAVID M·Filed 2008·Granted Mar 15, 2016·1 cites·40 claims
- 3978US2025241943A1Bi-functional co-polymer use for ophthalmic and other topical and local applicationsCALM WATER THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 4076US11135242B2Bi-functional co-polymer use for ophthalmic and other topical and local applicationsEYEON PARTICLE SCIENCES LLC·Filed 2019·Granted Oct 5, 2021·1 cites·29 claims
- 4176US4392848ACatheterizationPROCTER & GAMBLE·Filed 1979·Granted Jul 12, 1983·99 cites·20 claims
- 4275US2020155564A1Nanoparticulate Meloxicam FormulationsRECRO PHARMA INC·Filed 2019·Application pending·0 cites
- 4374US2021393672A1Bi-functional co-polymer use for ophthalmic and other topical and local applicationsCALM WATER THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4470US9050293B2Small molecule solubilization systemCOHEN DAVID M·Filed 2009·Granted Jun 9, 2015·0 cites·15 claims
- 4570US2021113580A1Nanoparticulate meloxicam formulationsBAUDAX BIO INC·Filed 2020·Application pending·0 cites
- 4669US5368837AX-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivativeSTERLING WINTHROP INC·Filed 1994·Granted Nov 29, 1994·36 cites·7 claims
- 4768US2016206565A1Bi-Functional Co-Polymer Use for Ophthalmic and Other Topical and Local ApplicationsEYEON PARTICLE SCIENCES LLC·Filed 2016·Application pending·0 cites
- 4867US2009324686A1Transscleral deliveryMACUSIGHT INC·Filed 2009·Application pending·0 cites
- 4967US2009324688A1Transscleral deliveryMACUSIGHT INC·Filed 2009·Application pending·0 cites
- 5067US2009324687A1Transscleral deliveryMACUSIGHT INC·Filed 2009·Application pending·0 cites
Showing the top 50 of 89 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →